Authors
Michael R Eber, Rebecca Costa, Stephanie Argetsinger, Mahnum Shahzad, Fang Zhang, J Frank Wharam, Dennis Ross-Degnan, Anita K Wagner
Published in
The American journal of managed care. Volume 32. Issue 10. Pages 545-547.
Abstract
Out-of-pocket (OOP) spending obligations associated with high-deductible health plans (HDHPs) may reduce health care utilization, but evidence on how enrollment in HDHPs affects use of oral targeted anticancer medications (OTAMs) is limited. We used difference-in-differences regression analyses to examine the associations among employer-mandated enrollment in an HDHP, OOP spending, and use of OTAMs in a commercially insured population between 2007 and 2021. Among users of OTAMs, we found that HDHP enrollment may have increased OOP spending but was not associated with reductions in the use of these anticancer agents over a 1-year follow-up period. Research should continue to examine the links among patient cost sharing, cancer care utilization, and spending trade-offs, particularly for low-income patients with cancer.
PMID:
43007287
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0